Fundraising Fox
🦊/People
Sign in

Stephen Thorne

Founder

Executive Officer, Promoter at Duo Oncology · Co-founder & Chief Scientific Officer at KaliVir Immunotherapeutics

Greater Pittsburgh Region

FoundedKaliVir Immunotherapeutics

Find your path to Stephen

924 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.

Paul KwanunlockedStephen: together at Stanford University (2003–2007)
×3Stephen: together at University of Oxford
×2Stephen: together at Cancerresearchuk
×6Stephen: together at Stanford University

About

Stephen Thorne is Chief Scientific Officer at KaliVir Immunotherapeutics. He has more than 15 years of research and leadership experience in the pre-clinical and translational development of cancer immunotherapies, including immune cell-based therapies, oncolytic viral therapies, and gene therapy. His areas of expertise include immunocompetent mouse cancer models, non-invasive molecular imaging in animal models, process development for complex biological therapies, and the development of immune monitoring and immune assays.

Executive Officer, Promoter at Duo Oncology

Intro paths

→

In turn, Stephen can intro founders to Duo Oncology's investors below.

Duo Oncology's investors · 5

Innovation WorksPittsburgh · $100K – $300K checks · since 2021National Institutes of Health (NIH)since 2023NuFundSan Diego · since 2021NuFund Venture GroupSan Diego · $1M checks · since 2021Ulu VenturesPalo Alto · $2M checks · since 2021

Co-founders at Duo Oncology

SL
SONG LIDirector, Promoter
JH
JING-ZHOU HOUExecutive Officer, Director, Promoter
SRSam Rothstein
Sam RothsteinCEO & Cofounder

Co-founder & Chief Scientific Officer at KaliVir Immunotherapeutics

Intro paths

→

In turn, Stephen can intro founders to KaliVir Immunotherapeutics's investors below.

KaliVir Immunotherapeutics's investors · 1

Premier PartnersSeoul

Experience

  1. KaliVir ImmunotherapeuticsChief Scientific Officercurrent2020 — present
  2. Duo OncologyBoard Membercurrent2020 — present
  3. Western Oncolytics Ltd.Chief Scientific Officercurrent2016 — presentGreater Pittsburgh Area
  4. University of PittsburghAssistant Professor
  5. Stanford UniversityResearch Associate2003 — 2007
  6. Cancer Research UKPostDoc2000 — 2002London, United Kingdom

Skills & more

Molecular Biology7Cell Culture4Cell Biology4Biochemistry2Animal Models3Lifesciences1Microscopy2Cell8Cancer8PCR1Genetics2Immunology2
+2 moreCancer ResearchDrug Discovery

From Stephen's professional profile.

Frequently asked questions

Who is Stephen Thorne?
Stephen Thorne is Chief Scientific Officer at KaliVir Immunotherapeutics. He has more than 15 years of research and leadership experience in the pre-clinical and translational development of cancer immunotherapies, including immune cell-based therapies, oncolytic viral therapies, and gene therapy. His areas of expertise include immunocompetent mouse cancer models, non-invasive molecular imaging in animal models, process development for complex biological therapies, and the development of immune monitoring and immune assays.
Where does Stephen Thorne work?
Stephen Thorne is Co-founder & Chief Scientific Officer of KaliVir Immunotherapeutics.
What companies did Stephen Thorne found?
Stephen Thorne founded KaliVir Immunotherapeutics.
Where did Stephen Thorne go to school?
Stephen Thorne studied at Imperial College London (Doctor of Philosophy (Ph.D.), Microbiology); University of Oxford (Bachelor of Applied Science (B.A.Sc.), Biochemistry).

Founder mafias

Same school

Shared employers